Literature DB >> 11901159

Human Herpesvirus 6 immediate-early 1 protein is a sumoylated nuclear phosphoprotein colocalizing with promyelocytic leukemia protein-associated nuclear bodies.

Annie Gravel1, Jean Gosselin, Louis Flamand.   

Abstract

Immediate-early (IE) proteins are the first proteins expressed following viral entry and play a crucial role in the initiation of infection. We report the cloning and characterization of a full-length IE1 transcript and protein (IE1B) from human herpesvirus 6 (HHV-6) variant B. The IE1B transcript consists of five exons (3720 nucleotides), three of which are coding for the IE1 protein. The 1078-amino acid-long IE1B protein is 62% identical and 75% similar to the 941-amino acid IE1 from HHV-6 variant A. IE1B protein can be detected at 4 h post-infection (P.I.), and it is distributed as small intranuclear structures. The maximal number of IE1 bodies ( approximately 10-12/nucleus) is detected at 12 h P.I. after which the IE1 bodies condense into 1-3 larger entities by 24-48 h P.I. During infection the IE1B protein is phosphorylated on serine and threonine residues. IE1B undergoes further post-translational modification with its conjugation to the small ubiquitin-like modifier (SUMO-1) peptide. IE1B colocalizes with SUMO-1 and promyelocytic leukemia nuclear bodies during infection as well as in transfection experiments. Finally, IE1 from variant B is a weaker transactivator than IE1 from variant A, when assayed using heterologous promoters. Overall, the characterization of the HHV-6 IE1B protein presented highlights the similarity and divergence between IE1 from both variants and provides useful information pertaining to the early phase of infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11901159     DOI: 10.1074/jbc.M200836200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

Review 1.  Human pathogens and the host cell SUMOylation system.

Authors:  Peter Wimmer; Sabrina Schreiner; Thomas Dobner
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  SUMOylation of the human cytomegalovirus 72-kilodalton IE1 protein facilitates expression of the 86-kilodalton IE2 protein and promotes viral replication.

Authors:  Michael Nevels; Wolfram Brune; Thomas Shenk
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  Inhibition of interleukin-2 gene expression by human herpesvirus 6B U54 tegument protein.

Authors:  Mathieu Iampietro; Guillaume Morissette; Annie Gravel; Louis Flamand
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

4.  Human herpesvirus 6 open reading frame U14 protein and cellular p53 interact with each other and are contained in the virion.

Authors:  Masaya Takemoto; Masato Koike; Yasuko Mori; Sayoko Yonemoto; Yumi Sasamoto; Kazuhiro Kondo; Yasuo Uchiyama; Koichi Yamanishi
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 5.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

6.  Inhibition of transcription of the beta interferon gene by the human herpesvirus 6 immediate-early 1 protein.

Authors:  Joanna Jaworska; Annie Gravel; Karin Fink; Nathalie Grandvaux; Louis Flamand
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

7.  Sumoylation of the Carboxy-Terminal of Human Cytomegalovirus DNA Polymerase Processivity Factor UL44 Attenuates Viral DNA Replication.

Authors:  Jun Chen; Guanlie Li; Haiqing He; Xin Li; Wenjing Niu; Di Cao; Ao Shen
Journal:  Front Microbiol       Date:  2021-04-21       Impact factor: 5.640

8.  Divergent susceptibilities of human herpesvirus 6 variants to type I interferons.

Authors:  Joanna Jaworska; Annie Gravel; Louis Flamand
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

Review 9.  Laboratory and clinical aspects of human herpesvirus 6 infections.

Authors:  Henri Agut; Pascale Bonnafous; Agnès Gautheret-Dejean
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 10.  Classification of HHV-6A and HHV-6B as distinct viruses.

Authors:  Dharam Ablashi; Henri Agut; Roberto Alvarez-Lafuente; Duncan A Clark; Stephen Dewhurst; Dario DiLuca; Louis Flamand; Niza Frenkel; Robert Gallo; Ursula A Gompels; Per Höllsberg; Steven Jacobson; Mario Luppi; Paolo Lusso; Mauro Malnati; Peter Medveczky; Yasuko Mori; Philip E Pellett; Joshua C Pritchett; Koichi Yamanishi; Tetsushi Yoshikawa
Journal:  Arch Virol       Date:  2013-11-06       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.